Press Releases
GBC in Taiwan received the coveted HR Asia Best Companies to Work for in Asia 2022 Award
TAIPEI, Taiwan, Aug. 19, 2022 — General Biologicals Corporation (GBC), a Taiwanese In-Vitro Diagnostic (IVD) specializing in Precision Diagnostics was honored with the “2022 HR Asia Best Companies to Work for in Asia”.
In all, 26,200 employees from 330 Taiwanese companies took part in HR Asia’s proprietary Total Engagement Assessment Model – ranking their own employers on metrics ranging from workplace happiness and team cohesion to employee advocacy and continued job motivation. The top 97 companies who made the cut off point this year are then named HR Asia Best Companies to work for in Asia 2022 for the Taiwanese market.
“HR Asia Best Companies to Work for in Asia is the only award that is judged solely by the nominees’ employees – making this the most transparent award of its kind. Equally important, with 15 markets, and over 400,000 surveys done each year – the program is also the most extensive awards for employee engagement and workplace excellence across the region”, says William Ng, group publisher of Business Media International, the owner of HR Asia.
Mr. Frank Lin, President of GBC, said that the group believes that talents are the cornerstone of the sustainable development of the enterprise. Since its establishment, it has adhered to the value-oriented development of all colleagues and the group, including various company benefits, focusing on the physical and mental health of colleagues, respecting the positions of colleagues in various departments, and maintaining colleagues at any time. Coordinating communication and feedback and encouraging the provision of resources for professional training of talents, etc., this award affirms the Group’s progress towards a happy enterprise and sustainable development goals.
About General Biologicals Corporation
Founded in 1984, General Biologicals Corporation (GBC) is a developer and manufacturer of diagnostics and pharmaceutical products headquartered in Taiwan. GBC develops high-quality in-vitro diagnostics for doctors to make clinical decisions in the areas of hepatitis, tumor markers, retrovirus, fertility, thyroid, and steroids. The company also provides anti-bacterial peptides (US FDA Clinical Trial Phase IIb) in the areas of pharmaceutical, cosmetics, and oral products.